CN106306970A - 靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 - Google Patents
靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 Download PDFInfo
- Publication number
- CN106306970A CN106306970A CN201610778717.8A CN201610778717A CN106306970A CN 106306970 A CN106306970 A CN 106306970A CN 201610778717 A CN201610778717 A CN 201610778717A CN 106306970 A CN106306970 A CN 106306970A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- vitamin
- powder
- weight
- cranberry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title claims abstract description 40
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 40
- 235000021014 blueberries Nutrition 0.000 title claims abstract description 40
- 240000000851 Vaccinium corymbosum Species 0.000 title claims abstract description 39
- 235000013361 beverage Nutrition 0.000 title claims abstract description 38
- 240000001717 Vaccinium macrocarpon Species 0.000 title claims abstract description 35
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 title claims abstract description 35
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 title claims abstract description 35
- 235000004634 cranberry Nutrition 0.000 title claims abstract description 35
- 239000007787 solid Substances 0.000 title claims abstract description 34
- 230000003712 anti-aging effect Effects 0.000 title abstract 3
- 239000000843 powder Substances 0.000 claims abstract description 113
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 42
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 42
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 40
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 38
- 229920001353 Dextrin Polymers 0.000 claims abstract description 21
- 239000004375 Dextrin Substances 0.000 claims abstract description 21
- 229920001202 Inulin Polymers 0.000 claims abstract description 21
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 21
- 244000269722 Thea sinensis Species 0.000 claims abstract description 21
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 21
- 235000019425 dextrin Nutrition 0.000 claims abstract description 21
- 235000009569 green tea Nutrition 0.000 claims abstract description 21
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 21
- 229940029339 inulin Drugs 0.000 claims abstract description 21
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 21
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 21
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 21
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 21
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 21
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 21
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 21
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 21
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 21
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 21
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 20
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 20
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 20
- 229960002477 riboflavin Drugs 0.000 claims abstract description 20
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 20
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 20
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 20
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims abstract description 19
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 19
- 235000019152 folic acid Nutrition 0.000 claims abstract description 19
- 239000011724 folic acid Substances 0.000 claims abstract description 19
- 229960000304 folic acid Drugs 0.000 claims abstract description 19
- 229960003495 thiamine Drugs 0.000 claims abstract description 19
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 19
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 19
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 19
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 16
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 16
- 239000001527 calcium lactate Substances 0.000 claims abstract description 16
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 16
- 230000036039 immunity Effects 0.000 claims abstract description 7
- 230000002708 enhancing effect Effects 0.000 claims abstract description 5
- 230000037303 wrinkles Effects 0.000 claims abstract description 5
- 240000005481 Salvia hispanica Species 0.000 claims description 19
- 235000001498 Salvia hispanica Nutrition 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 14
- 230000008685 targeting Effects 0.000 claims description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 230000008439 repair process Effects 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 235000021028 berry Nutrition 0.000 claims description 5
- 229960005069 calcium Drugs 0.000 claims description 5
- 235000001465 calcium Nutrition 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 150000003254 radicals Chemical class 0.000 claims description 4
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 235000005979 Citrus limon Nutrition 0.000 abstract 1
- 244000131522 Citrus pyriformis Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 235000016623 Fragaria vesca Nutrition 0.000 abstract 1
- 240000009088 Fragaria x ananassa Species 0.000 abstract 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 abstract 1
- 235000020235 chia seed Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000012680 lutein Nutrition 0.000 abstract 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 1
- 229960005375 lutein Drugs 0.000 abstract 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 1
- 239000001656 lutein Substances 0.000 abstract 1
- 230000002000 scavenging effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 1
- 239000000047 product Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920000377 Sinistrin Polymers 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及一种靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料，其包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸、乳酸钙。本发明的蓝莓蔓越莓固体饮料适口性好，靶向修复细胞、清除自由基，从而去除皱纹、增强免疫力、延缓衰老。
Description
技术领域
本发明涉及医疗保健领域，具体涉及一种靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料，其包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸、乳酸钙。本发明的蓝莓蔓越莓固体饮料适口性好，靶向修复细胞、清除自由基，从而去除皱纹、增强免疫力、延缓衰老。
背景技术
固体饮料属于软饮料的一类，主要分为蛋白型固体饮料(包含氨基酸饮料)和普通型固体饮料。蛋白型固体饮料是指以乳及乳制品、蛋及蛋制品、其他动植物蛋白、氨基酸等为主要原料，添加或不添加辅料制成的、蛋白质含量大于或等于4％的制品，常见的有豆奶粉、核桃粉、麦乳精、氨康源氨基酸等；普通型固体饮料是指以果粉或经烘烤的咖啡、茶叶、菊花、茅根等植物提取物为主要原料，添加或不添加其他辅料制成的、蛋白质含量低于4％的制品。常见的有酸梅粉、菊花晶、速溶茶粉、茅根精、氨基酸饮料等。
一直以来，固体饮料因品种多样、风味独特、易于存放而备受消费者青睐；尤其是那些富含维生素、矿物质、氨基酸等营养成分的固体饮料，可以及时补充人体代谢所需营养，更成为了许多人生活中离不开的好伴侣。
固体饮料是由液体饮料除去水分而制成的，去除水分的目的：一是防止被干燥饮料由于其本身的酶或微生物引起的变质或腐败，以利储藏；二是便于储存和运输。
与液体饮料相比，固体饮料具有如下特点：质量显著减轻，体积显著变小，携带方便；风味好，速溶性好，应用范围广，饮用方便；易于保持卫生；包装简易，运输方便。
目前市场上其大多数仅有补充糖分等营养素的作用，少部分还含有对人体有害的添加剂，一种既具有常规固体饮料的优点又具有额外美容/保健/治疗功能的固体饮料对于消费者是非常有利的。
发明内容
本发明人研发了一种靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料，其包含包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸、乳酸钙。本发明的蓝莓蔓越莓固体饮料适口性好，靶向修复细胞、清除自由基，从而去除皱纹、增强免疫力、延缓衰老。
本发明的第一方面提供一种靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料，其包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸和乳酸钙。
在一个实施方案中，本发明的蓝莓蔓越莓固体饮料包含10-30重量份的蓝莓粉、10-30重量份的蔓越莓粉、1-10重量份的绿茶粉、5-15重量份的草莓粉、5-15重量份的菊粉、5-15重量份的柠檬粉、5-15重量份的奇亚籽、5-15重量份的抗性糊精、1-10重量份的异麦芽酮糖、0.0005-0.0015重量份的叶黄素、0.005-0.015重量份的姜黄、0.01-0.3重量份的维生素C、0.0000005-0.0000025重量份的维生素D3、0.001-0.003重量份的维生素B1、0.001-0.003重量份的维生素B2、0.01-0.05重量份的烟酸、0.001-0.003重量份的维生素B6、0.000001-0.00001重量份的维生素B12、0.0001-0.001重量份的叶酸和1-10重量份的乳酸钙。
在一个实施方案中，本发明的蓝莓蔓越莓固体饮料包含15-25重量份的蓝莓粉15-25重量份的蔓越莓粉、3-7重量份的绿茶粉、8-12重量份的草莓粉、8-12重量份的菊粉、8-12重量份的柠檬粉、8-12重量份的奇亚籽、8-12重量份的抗性糊精、3-7重量份的异麦芽酮糖、0.0008-0.0012重量份的叶黄素、0.008-0.012重量份的姜黄、0.05-0.25重量份的维生素C、0.000001-0.000002重量份的维生素D3、0.0015-0.0025重量份的维生素B1、0.0015-0.0025重量份的维生素B2、0.02-0.04重量份的烟酸、0.0015-0.0025重量份的维生素B6、0.000003-0.000008重量份的维生素B12、0.0003-0.0008重量份的叶酸和3-7重量份的乳酸钙。
在一个实施方案中，本发明的蓝莓蔓越莓固体饮料包含20重量份的蓝莓粉、20重量份的蔓越莓粉、5重量份的绿茶粉、10重量份的草莓粉、10重量份的菊粉、10重量份的柠檬粉、10重量份的奇亚籽、10重量份的抗性糊精、5重量份的异麦芽酮糖、0.001重量份的叶黄素、0.01重量份的姜黄、0.22重量份的维生素C、0.0000015重量份的维生素D3、0.002重量份的维生素B1、0.002重量份的维生素B2、0.03重量份的烟酸、0.002重量份的维生素B6、0.000006重量份的维生素B12、0.00055重量份的叶酸和5重量份的乳酸钙。
本发明的第二方面提供制备本发明第一方面所述的蓝莓蔓越莓固体饮料的方法，包括以下步骤：称量、配料、粉碎、混合、包装。
本发明的第三方面提供一种组合物在制备用于靶向修复细胞、清除自由基，从而去除皱纹、增强免疫力、延缓衰老的药物和保健品中的用途，所述组合物包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸和乳酸钙。
在一个实施方案中，所述组合物包含10-30重量份的蓝莓粉、10-30重量份的蔓越莓粉、1-10重量份的绿茶粉、5-15重量份的草莓粉、5-15重量份的菊粉、5-15重量份的柠檬粉、5-15重量份的奇亚籽、5-15重量份的抗性糊精、1-10重量份的异麦芽酮糖、0.0005-0.0015重量份的叶黄素、0.005-0.015重量份的姜黄、0.01-0.3重量份的维生素C、0.0000005-0.0000025重量份的维生素D3、0.001-0.003重量份的维生素B1、0.001-0.003重量份的维生素B2、0.01-0.05重量份的烟酸、0.001-0.003重量份的维生素B6、0.000001-0.00001重量份的维生素B12、0.0001-0.001重量份的叶酸和1-10重量份的乳酸钙。
在一个实施方案中，所述组合物包含15-25重量份的蓝莓粉15-25重量份的蔓越莓粉、3-7重量份的绿茶粉、8-12重量份的草莓粉、8-12重量份的菊粉、8-12重量份的柠檬粉、8-12重量份的奇亚籽、8-12重量份的抗性糊精、3-7重量份的异麦芽酮糖、0.0008-0.0012重量份的叶黄素、0.008-0.012重量份的姜黄、0.05-0.25重量份的维生素C、0.000001-0.000002重量份的维生素D3、0.0015-0.0025重量份的维生素B1、0.0015-0.0025重量份的维生素B2、0.02-0.04重量份的烟酸、0.0015-0.0025重量份的维生素B6、0.000003-0.000008重量份的维生素B12、0.0003-0.0008重量份的叶酸和3-7重量份的乳酸钙。
在一个实施方案中，所述组合物包含20重量份的蓝莓粉、20重量份的蔓越莓粉、5重量份的绿茶粉、10重量份的草莓粉、10重量份的菊粉、10重量份的柠檬粉、10重量份的奇亚籽、10重量份的抗性糊精、5重量份的异麦芽酮糖、0.001重量份的叶黄素、0.01重量份的姜黄、0.22重量份的维生素C、0.0000015重量份的维生素D3、0.002重量份的维生素B1、0.002重量份的维生素B2、0.03重量份的烟酸、0.002重量份的维生素B6、0.000006重量份的维生素B12、0.00055重量份的叶酸和5重量份的乳酸钙。
具体实施方式
本发明使用的原辅料均可由市场购得，其中：
绿茶粉应符合NY/T 2672的要求。
蓝莓粉、蔓越莓粉、草莓粉、柠檬粉呈粉末状，无结块，应符合NY/T 1884的要求。
菊粉应符合《关于批菊粉、多聚果糖为新资源食品的公告(卫计委2009年第5号)》的要求。
奇亚籽应符合《关于批准塔格糖等6种新食品原料的公告(卫计委2014年第10号)》的要求。
抗性糊精(又称可溶性膳食纤维)应符合《关于批准中长链脂肪酸食用油和小麦低聚肽作为新资源食品的公告卫计委2012年第16号)》的要求。
异麦芽酮糖应符合QB 1581的要求。
叶黄素应符合GB 26405的要求。
姜黄应符合GB 1886.60的要求。
维生素B1应符合GB 14751的要求。
维生素B2应符合GB 14752的要求。
维生素B6应符合GB 14753的要求。
维生素C应符合GB 14754的要求。
烟酸应符合GB 14757的要求。
维生素D3、维生素B12应符合《中华人民共和国药典》2015年版二部的要求。
叶酸应符合GB 15570的要求。
乳酸钙应符合GB 6226的要求。
以上原辅料还应符合GB 2761、GB2762、GB2763的要求。
本发明所述的称量、配料、粉碎、混合、包装均为本领域公知的含义，本发明对上述过程并无特别要求。
实施例
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
一、本发明固体饮料的制备
取20重量份的蓝莓粉、20重量份的蔓越莓粉、5重量份的绿茶粉、10重量份的草莓粉、10重量份的菊粉、10重量份的柠檬粉、10重量份的奇亚籽、10重量份的抗性糊精、5重量份的异麦芽酮糖、0.001重量份的叶黄素、0.01重量份的姜黄、0.22重量份的维生素C、0.0000015重量份的维生素D3、0.002重量份的维生素B1、0.002重量份的维生素B2、0.03重量份的烟酸、0.002重量份的维生素B6、0.000006重量份的维生素B12、0.00055重量份的叶酸和5重量份的乳酸钙，将大颗粒的物料在粉碎机中粉碎，然后将所有物料一起放入混料机中混合均匀，在50℃下干燥数小时；将干燥后的物料按50g/小袋进行包装。
制备得到的固体饮料满足以下标准：
使用方法：每次取一袋本发明固体饮料(50g)，加适量(例如500ml)饮用水搅拌均匀，随时饮用。
二.使用效果
实验方法：将60只昆明种小鼠(雌雄各半，8周龄作用，约25-35g)随机平均分为试验组与对照组各30只，每日分别加喂本发明的固体饮料1克以及市售某果珍粉1克(以干重计)，6周后，测量各组的脾指数和胸腺指数。本领域公知，脾指数和胸腺指数在一定程度上与免疫力为正向关系。结果见下表。
表1
| 组别 | 脾指数(％) | 胸腺指数(％) |
| 试验组 | 4.27±0.068 | 2.95+0.061 |
| 对照组 | 3.91±0.081 | 2.54±0.073 |
从表1可以看出，本发明的产品相对于对照组可以显著提高小鼠的脾指数和胸腺指数，说明本发明产品能够显著提高免疫力。
申请人声明，本发明通过上述实施例来说明本发明的详细方法，但本发明并不局限于上述详细方法，即不意味着本发明必须依赖上述详细方法才能实施。所属技术领域的技术人员应该明了，对本发明的任何改进，对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等，均落在本发明的保护范围和公开范围之内。
Claims (9)
1.一种靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料，其包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸、乳酸钙。
2.如权利要求1所述的蓝莓蔓越莓固体饮料，其包含10-30重量份的蓝莓粉、10-30重量份的蔓越莓粉、1-10重量份的绿茶粉、5-15重量份的草莓粉、5-15重量份的菊粉、5-15重量份的柠檬粉、5-15重量份的奇亚籽、5-15重量份的抗性糊精、1-10重量份的异麦芽酮糖、0.0005-0.0015重量份的叶黄素、0.005-0.015重量份的姜黄、0.01-0.3重量份的维生素C、0.0000005-0.0000025重量份的维生素D3、0.001-0.003重量份的维生素B1、0.001-0.003重量份的维生素B2、0.01-0.05重量份的烟酸、0.001-0.003重量份的维生素B6、0.000001-0.00001重量份的维生素B12、0.0001-0.001重量份的叶酸和1-10重量份的乳酸钙。
3.如权利要求1所述的蓝莓蔓越莓固体饮料，其包含15-25重量份的蓝莓粉15-25重量份的蔓越莓粉、3-7重量份的绿茶粉、8-12重量份的草莓粉、8-12重量份的菊粉、8-12重量份的柠檬粉、8-12重量份的奇亚籽、8-12重量份的抗性糊精、3-7重量份的异麦芽酮糖、0.0008-0.0012重量份的叶黄素、0.008-0.012重量份的姜黄、0.05-0.25重量份的维生素C、0.000001-0.000002重量份的维生素D3、0.0015-0.0025重量份的维生素B1、0.0015-0.0025重量份的维生素B2、0.02-0.04重量份的烟酸、0.0015-0.0025重量份的维生素B6、0.000003-0.000008重量份的维生素B12、0.0003-0.0008重量份的叶酸和3-7重量份的乳酸钙。
4.如权利要求1所述的蓝莓蔓越莓固体饮料，其包含20重量份的蓝莓粉、20重量份的蔓越莓粉、5重量份的绿茶粉、10重量份的草莓粉、10重量份的菊粉、10重量份的柠檬粉、10重量份的奇亚籽、10重量份的抗性糊精、5重量份的异麦芽酮糖、0.001重量份的叶黄素、0.01重量份的姜黄、0.22重量份的维生素C、0.0000015重量份的维生素D3、0.002重量份的维生素B1、0.002重量份的维生素B2、0.03重量份的烟酸、0.002重量份的维生素B6、0.000006重量份的维生素B12、0.00055重量份的叶酸和5重量份的乳酸钙。
5.制备如权利要求1-4任一项所述的蓝莓蔓越莓固体饮料的方法，包括以下步骤：称量、配料、粉碎、混合、包装。
6.一种组合物在制备用于靶向修复细胞、清除自由基，从而去除皱纹、增强免疫力、延缓衰老的药物和保健品中的用途，所述组合物包含蓝莓粉、蔓越莓粉、绿茶粉、草莓粉、菊粉、柠檬粉、奇亚籽、抗性糊精、异麦芽酮糖、叶黄素、姜黄、维生素C、维生素D3、维生素B1、维生素B2、烟酸、维生素B6、维生素B12、叶酸和乳酸钙。
7.如权利要求6所述的用途，其中所述组合物包含10-30重量份的蓝莓粉、10-30重量份的蔓越莓粉、1-10重量份的绿茶粉、5-15重量份的草莓粉、5-15重量份的菊粉、5-15重量份的柠檬粉、5-15重量份的奇亚籽、5-15重量份的抗性糊精、1-10重量份的异麦芽酮糖、0.0005-0.0015重量份的叶黄素、0.005-0.015重量份的姜黄、0.01-0.3重量份的维生素C、0.0000005-0.0000025重量份的维生素D3、0.001-0.003重量份的维生素B1、0.001-0.003重量份的维生素B2、0.01-0.05重量份的烟酸、0.001-0.003重量份的维生素B6、0.000001-0.00001重量份的维生素B12、0.0001-0.001重量份的叶酸和1-10重量份的乳酸钙。
8.如权利要求6所述的用途，其中所述组合物包含15-25重量份的蓝莓粉15-25重量份的蔓越莓粉、3-7重量份的绿茶粉、8-12重量份的草莓粉、8-12重量份的菊粉、8-12重量份的柠檬粉、8-12重量份的奇亚籽、8-12重量份的抗性糊精、3-7重量份的异麦芽酮糖、0.0008-0.0012重量份的叶黄素、0.008-0.012重量份的姜黄、0.05-0.25重量份的维生素C、0.000001-0.000002重量份的维生素D3、0.0015-0.0025重量份的维生素B1、0.0015-0.0025重量份的维生素B2、0.02-0.04重量份的烟酸、0.0015-0.0025重量份的维生素B6、0.000003-0.000008重量份的维生素B12、0.0003-0.0008重量份的叶酸和3-7重量份的乳酸钙。
9.如权利要求6所述的用途，其中所述组合物包含20重量份的蓝莓粉、20重量份的蔓越莓粉、5重量份的绿茶粉、10重量份的草莓粉、10重量份的菊粉、10重量份的柠檬粉、10重量份的奇亚籽、10重量份的抗性糊精、5重量份的异麦芽酮糖、0.001重量份的叶黄素、0.01重量份的姜黄、0.22重量份的维生素C、0.0000015重量份的维生素D3、0.002重量份的维生素B1、0.002重量份的维生素B2、0.03重量份的烟酸、0.002重量份的维生素B6、0.000006重量份的维生素B12、0.00055重量份的叶酸和5重量份的乳酸钙。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610778717.8A CN106306970A (zh) | 2016-08-31 | 2016-08-31 | 靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610778717.8A CN106306970A (zh) | 2016-08-31 | 2016-08-31 | 靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106306970A true CN106306970A (zh) | 2017-01-11 |
Family
ID=57789529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610778717.8A Pending CN106306970A (zh) | 2016-08-31 | 2016-08-31 | 靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106306970A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106901089A (zh) * | 2017-03-08 | 2017-06-30 | 广东食品药品职业学院 | 一种含姜黄素组合物的保健饮料 |
| CN107980997A (zh) * | 2018-01-06 | 2018-05-04 | 佛山推启农业研究院（普通合伙） | 一种蓝莓苦丁茶饮料及其制备方法 |
| CN108464419A (zh) * | 2018-04-16 | 2018-08-31 | 东莞市圣露食品有限公司 | 改善氢氧化钙口感的沙棘柠檬固体饮料 |
| CN109601803A (zh) * | 2018-11-07 | 2019-04-12 | 江西颐迪科技有限公司 | 一种能消除老年人体味并有助健康的饮料及其制作方法 |
| CN110959796A (zh) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | 一种运动健身伴侣固体饮料及其制备方法 |
| CN114403430A (zh) * | 2021-10-28 | 2022-04-29 | 海南三风友制药有限公司 | 一种使身体发香的营养代餐饮品组合物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101744338A (zh) * | 2008-12-02 | 2010-06-23 | 光明乳业股份有限公司 | 一种固体饮料的制备方法及由其制得的固体饮料 |
| CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
| CN105661245A (zh) * | 2016-01-29 | 2016-06-15 | 江苏微康生物科技有限公司 | 一种益生菌型果蔬酵素固体饮料 |
| CN105876584A (zh) * | 2016-04-12 | 2016-08-24 | 靳林潮 | 固体饮料及其制备方法 |
-
2016
- 2016-08-31 CN CN201610778717.8A patent/CN106306970A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101744338A (zh) * | 2008-12-02 | 2010-06-23 | 光明乳业股份有限公司 | 一种固体饮料的制备方法及由其制得的固体饮料 |
| CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
| CN105661245A (zh) * | 2016-01-29 | 2016-06-15 | 江苏微康生物科技有限公司 | 一种益生菌型果蔬酵素固体饮料 |
| CN105876584A (zh) * | 2016-04-12 | 2016-08-24 | 靳林潮 | 固体饮料及其制备方法 |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106901089A (zh) * | 2017-03-08 | 2017-06-30 | 广东食品药品职业学院 | 一种含姜黄素组合物的保健饮料 |
| CN107980997A (zh) * | 2018-01-06 | 2018-05-04 | 佛山推启农业研究院（普通合伙） | 一种蓝莓苦丁茶饮料及其制备方法 |
| CN108464419A (zh) * | 2018-04-16 | 2018-08-31 | 东莞市圣露食品有限公司 | 改善氢氧化钙口感的沙棘柠檬固体饮料 |
| CN109601803A (zh) * | 2018-11-07 | 2019-04-12 | 江西颐迪科技有限公司 | 一种能消除老年人体味并有助健康的饮料及其制作方法 |
| CN110959796A (zh) * | 2019-12-25 | 2020-04-07 | 河南佳禾康生物食品科技有限公司 | 一种运动健身伴侣固体饮料及其制备方法 |
| CN114403430A (zh) * | 2021-10-28 | 2022-04-29 | 海南三风友制药有限公司 | 一种使身体发香的营养代餐饮品组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106306970A (zh) | 靶向修复受损细胞实现抗衰老的蓝莓蔓越莓固体饮料 | |
| Baschali et al. | Traditional low-alcoholic and non-alcoholic fermented beverages consumed in European countries: A neglected food group | |
| CN102907744B (zh) | 一种山药枸杞固体饮料及其制备方法 | |
| CN105815646A (zh) | 一种158素食全餐固体饮料及其制备方法 | |
| CN102726566A (zh) | 一种花茶的配方和制备方法以及花茶饮料 | |
| CN102986981A (zh) | 一种大麦若叶茶的制备方法 | |
| CN102228303A (zh) | 一种果醋泡腾片固体制剂及其加工工艺 | |
| CN104970419A (zh) | 一种葡萄固体饮料 | |
| CN103082376A (zh) | 一种以枸杞为主的固体饮品及其制备方法 | |
| CN101317658B (zh) | 玉米复合营养浓浆及其制备方法 | |
| CN104256757A (zh) | 一种迷迭香藜麦香蕉汁 | |
| CN110731442A (zh) | 一种祛湿消水肿的活性肽固体饮料及其制备方法 | |
| CN104012656A (zh) | 一种果蔬奶茶配方 | |
| CN106360236A (zh) | 靶向排毒、祛湿、祛痘、祛斑的营养膳食纤维固体饮料 | |
| CN101322517A (zh) | 浓缩大麦茶制备方法 | |
| CN104621484A (zh) | 一种植物蛋白粉 | |
| CN104814097A (zh) | 一种绿豆抹茶味营养饼干 | |
| CN104137886A (zh) | 一种柠檬草茶醋奶茶及其制备方法 | |
| CN105077499A (zh) | 一种低糖柠檬固体饮料的组分及其制备方法 | |
| CN100490681C (zh) | 一种含有余甘子提取物的保健食品 | |
| CN102204590B (zh) | 具有降火功能的乳制品 | |
| JP2017197461A (ja) | カルシウム吸収促進用組成物 | |
| CN101331905A (zh) | 用冷冻干燥法制作香菇红枣茶 | |
| CN102696835A (zh) | 袋泡花蕾马黛茶 | |
| CN108624441A (zh) | 一种具有缓解疲劳作用的酒味饮料的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170111 |
|
| WD01 | Invention patent application deemed withdrawn after publication |